Skip to main content
Caplight Logo









MediGence

MediGence

Private
NoidaHealthcare & Life Scienceshttps://medigence.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MediGence operates in Healthcare & Life Sciences and is based in Noida. It was founded in 2016.

MediGence is a healthcare technology company that operates a global platform facilitating medical travel, teleconsultations, and personalized treatment planning for patients seeking overseas healthcare.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, E-commerce

Business Model

B2C

Customer Profile

Marketplace Commission, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MediGence Comparables

Compare MediGence with similar companies based on industry and business-model similarity.

MediGence comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lyfboat
93%
Healthtrip
93%
Booking Health
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MediGence Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for MediGence. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ameet Bansall

Founder & CEO

Founding Team

Vijita Jayan

Chief Operating Officer, Director

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2026

    Monthly visitors increased 32% MoM.

  • Jun 19, 2026

    Monthly visitors increased 31% MoM, reaching 219.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

MediGence Filings

Explore SEC and related filing metadata, where available.

MediGence filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MediGence's valuation, stock price, and market status.

Is MediGence a public or private company?

MediGence is a private company.

What is the current stock price of MediGence?

MediGence is a private company, so its shares have no public market price. Caplight tracks MediGence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MediGence worth (valuation)?

Valuation information for MediGence is not publicly available.

Can I buy MediGence stock?

MediGence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MediGence's last funding round?

Funding round information for MediGence is not publicly available.

Who are the main investors in MediGence?

Investor information for MediGence is not publicly disclosed.

Will MediGence IPO soon?

No public IPO plans have been announced for MediGence.

How can I track MediGence secondary market activity?

Caplight tracks bids, offers, and trades in MediGence's shares on secondary markets.

Firmographic Details

HeadquartersNoida
Employee Range53
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?